Oncologia
Estudo randomizado | Avaliação geriátrica pode reduzir os efeitos tóxicos da quimioterapia em idosos com câncer.
28 Out, 2021 | 15:55hGeriatric Assessment–Driven Intervention (GAIN) on Chemotherapy-Related Toxic Effects in Older Adults With Cancer: A Randomized Clinical Trial – JAMA Oncology (link para o resumo – $ para o texto completo)
Comentário no Twitter
Randomized trial with 604 older patients with cancer starting a new chemo regimen showed the incidence of grade 3 or higher chemo-related toxic effects was significantly lower in those who underwent a geriatric assessment-driven intervention https://t.co/QtOgmLDRU1
— JAMA Oncology (@JAMAOnc) October 1, 2021
Estudo randomizado | Irradiação eletiva de linfonodo mamário interno não aumenta a sobrevida livre de doença ou a sobrevida geral na maioria das mulheres com câncer de mama com linfonodo acometido.
27 Out, 2021 | 12:31hEffect of Elective Internal Mammary Node Irradiation on Disease-Free Survival in Women With Node-Positive Breast Cancer: A Randomized Phase 3 Clinical Trial – JAMA Oncology (gratuito por tempo limitado)
Comentário: No Survival Benefit for Internal Mammary Node Irradiation in Breast Cancer — Women with medially or centrally located tumors may be candidates, however, says researcher – MedPage Today (necessário cadastro gratuito)
Comentário no Twitter
Phase III randomized study evaluated the role of internal mammary node irradiation (IMNI) in node-positive #breastcancer. IMNI did not improve the DFS in unselected patients, but did improve DFS in patients with medially or centrally located tumors https://t.co/tw4ZrHn5wn pic.twitter.com/34ye3TR9MA
— JAMA Oncology (@JAMAOnc) October 25, 2021
Revisão sistemática | Cuidado virtual para pacientes com câncer.
27 Out, 2021 | 12:21hVirtual Care in Patients with Cancer: A Systematic Review – Current Oncology
Estudo randomizado | Gastrectomia distal laparoscópica vs. aberta para câncer gástrico localmente avançado.
26 Out, 2021 | 11:20hLaparoscopic vs Open Distal Gastrectomy for Locally Advanced Gastric Cancer: Five-Year Outcomes From the CLASS-01 Randomized Clinical Trial – JAMA Surgery (gratuito por tempo limitado)
Comentário no Twitter
It is not clear whether laparoscopic (LDG) and open distal gastrectomy (ODG) produce similar long-term outcomes in advanced #gastriccancer. CLASS-01 trial firstly shows LDG results in similar 5-year OS compared to ODG in advanced gastric cancer https://t.co/uUBcLFeqsY
— JAMA Surgery (@JAMASurgery) October 20, 2021
Arritmias ventriculares ameaçadoras à vida induzidas por medicamentos anticâncer: um estudo de farmacovigilância da OMS.
26 Out, 2021 | 11:15hEditorial: QT prolongation and cancer therapeutics: a coming Tempest or Much Ado About Nothing?
Comentário: Anticancer Drug-Induced Life-Threatening Ventricular Arrhythmias – American College of Cardiology
Conteúdo relacionado: AHA Scientific Statement: Recognition, prevention, and management of arrhythmias and autonomic disorders in cardio-oncology.
Comentário no Twitter
Anticancer drug-induced life-threatening ventricular arrhythmias: a World Health Organization @WHO pharmacovigilance study https://t.co/ONAIFmOjZV #EHJ #ESCYoung #ventriculararrhythmias #cardiotwitter @ehj_ed @rladeiraslopes pic.twitter.com/t0fjoVy7fw
— European Society of Cardiology Journals (@ESC_Journals) August 23, 2021
Diretriz NCCN | Doença tromboembólica venosa associada a câncer.
21 Out, 2021 | 11:25hConteúdos relacionados:
ASH 2021 guidelines for prevention and treatment of venous thromboembolism in patients with cancer
Review: venous and arterial thromboembolism in patients with cancer.
Diretriz de prática clínica da ESMO para diagnóstico, estadiamento e tratamento de pacientes com câncer de mama metastático.
21 Out, 2021 | 11:12hComunicado de imprensa: metastatic breast cancer: new ESMO guideline with evidence-based recommendations – European Society of Medical Oncology
Estudo randomizado | Nivolumabe vs. placebo em pacientes com mesotelioma maligno recidivante.
21 Out, 2021 | 11:10h
Comentário no Twitter
CONFIRM Trial: a phase III study demonstrated longer PFS and OS with Nivolumab compared with Placebo in patients with Pleural or Peritoneal Malignant Mesothelioma who have progressed following platinum-based chemotherapy @OncoAlert #LCSM https://t.co/jKoKXEXgpB
— Dipesh Uprety MD FACP (@dipeshuprety4) October 15, 2021
Estudo de coorte | Retenção urinária aguda pode ser um marcador clínico de câncer de próstata oculto e outras neoplasias urogenitais, colorretais e neurológicas.
20 Out, 2021 | 11:45hAcute urinary retention and risk of cancer: population based Danish cohort study – The BMJ
Comentário no Twitter
This study finds that a first diagnosis of acute urinary retention in patients aged 50 years or older was a clinical marker not only for prostate cancer but also for other urogenital cancers and colorectal and neurological cancershttps://t.co/0f1Z93cqR0 @dceaarhus
— The BMJ (@bmj_latest) October 19, 2021